BridgeBio Oncology and Helix Acquisition Announce Business Merger to Advance RAS, PI3Kα Medicines

Read more

Magnet Biomedicine and Lilly Partner to Develop Novel Molecular Glue Medicines

Read more

FDA Grants Priority Review to Sobi’s sBLA for Gamifant (emapalumab-lzsg)

Read more

Medigene and EpimAb Partner on Co-Development of TCR-Guided T Cell Engagers

Read more

FDA Accepts BLA for Odronextamab in Treating Relapsed/Refractory Follicular Lymphoma

Read more

Lilly to Exceed $50 Billion in U.S. Manufacturing Investment, Doubling Since 2020

Read more

Sarclisa Approved in Japan for Newly Diagnosed Multiple Myeloma Patients

Read more

RedHill Licenses RHB-102 to Hyloris for Global Commercialization, Potentially Worth $60M

Read more

Summit Therapeutics Partners with Pfizer to Trial Ivonescimab with ADCs

Read more

Mirum’s CTEXLI Tablets FDA-Approved for Cerebrotendinous Xanthomatosis

Read more